Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Rises By 19.0%

BioNexus Gene Lab Corp. (NASDAQ:BGLCGet Free Report) saw a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 224,800 shares, a growth of 19.0% from the June 30th total of 188,900 shares. Based on an average trading volume of 160,500 shares, the short-interest ratio is presently 1.4 days. Approximately 2.9% of the shares of the company are sold short.

BioNexus Gene Lab Stock Performance

Shares of BGLC traded down $0.02 during trading hours on Friday, hitting $0.49. The stock had a trading volume of 51,409 shares, compared to its average volume of 122,678. BioNexus Gene Lab has a 12 month low of $0.31 and a 12 month high of $3.87. The stock has a fifty day moving average price of $0.49 and a 200 day moving average price of $0.60.

BioNexus Gene Lab (NASDAQ:BGLCGet Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. BioNexus Gene Lab had a negative return on equity of 30.74% and a negative net margin of 27.24%. The firm had revenue of $2.38 million during the quarter.

Institutional Trading of BioNexus Gene Lab

An institutional investor recently raised its position in BioNexus Gene Lab stock. Virtu Financial LLC raised its stake in shares of BioNexus Gene Lab Corp. (NASDAQ:BGLCFree Report) by 79.9% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 47,037 shares of the company’s stock after purchasing an additional 20,888 shares during the period. Virtu Financial LLC owned 0.27% of BioNexus Gene Lab worth $33,000 as of its most recent SEC filing. Institutional investors and hedge funds own 18.85% of the company’s stock.

BioNexus Gene Lab Company Profile

(Get Free Report)

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.

Featured Articles

Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.